Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Young

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Annals of the Rheumatic Diseases|December 20, 2023
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of boneJonathan Phillips, Deepak Subedi, Steff C Lewis, et al.
BMJ Open|September 7, 2019
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent <i>SQSTM1</i>-mediated Paget's disease of boneOwen Cronin, Laura Forsyth, Kirsteen Goodman, et al.
The Lancet. Rheumatology|January 17, 2024
Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trialsJessica R Tarn, Nadia Howard-Tripp, Dennis W Lendrem, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Annals of the Rheumatic Diseases|December 20, 2023
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of boneJonathan Phillips, Deepak Subedi, Steff C Lewis, et al.
BMJ Open|September 7, 2019
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent <i>SQSTM1</i>-mediated Paget's disease of boneOwen Cronin, Laura Forsyth, Kirsteen Goodman, et al.
The Lancet. Rheumatology|January 17, 2024
Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trialsJessica R Tarn, Nadia Howard-Tripp, Dennis W Lendrem, et al.
Pageof 8